Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity

被引:11
作者
Bazzan, M
Gruden, G
Stella, S
Vaccarino, A
Tamponi, G
Olivetti, C
Giunti, S
Cavallo-Perin, P
机构
[1] Univ Turin, Dept Haematol & Onco Haematol, I-10126 Turin, Italy
[2] Univ Turin, Dept Internal Med, Turin, Italy
关键词
diabetes; atherosclerosis; procoagulant activity; monocytes;
D O I
10.1007/s001250050985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microalbuminuria, the early phase of diabetic nephropathy, is associated with an increased risk of atherothrombosis. Monocytes play an important part in the pathogenesis of atherosclerosis and in the activation of haemostasis. However, procoagulant activity is poorly understood in Type I (insulin-dependent) diabetes mellitus, particularly in the presence of microalbuminuria. This study aimed to evaluate spontaneous and endotoxin-induced monocyte procoagulant activity in insulin-dependent diabetic patients with normoalbuminuria or microalbuminuria. Seventeen patients with microalbuminuria, 28 with normoalbuminuria and 26 healthy control subjects matched for age, sex, body mass index and smoking habit were studied. Mononuclear cells from peripheral venous blood were incubated with or without bacterial lypopolysaccharide. Spontaneous procoagulant activity and procoagulant activity after 3 h and 6 h of incubation were calculated. Spontaneous procoagulant activity values were similar in the three groups. After 3h and 6h incubation with bacterial lypopolysaccharide, procoagulant activity values were slightly, but not statistically significantly, higher in the normoalbuminuric diabetic group than in control group, and significantly higher in microalbuminuric diabetic group than in control group (p < 0.01). The increased endotoxin-induced monocyte procoagulant activity helps to explain the link between microalbuminuria and the increased risk of atherothrombosis in patients with Type I diabetes.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 29 条
[1]  
ALTIERI DC, 1993, BLOOD, V81, P569
[2]  
Bazzan M, 1996, HAEMOSTASIS, V26, P157
[3]   Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus [J].
Berg, TJ ;
Bangstad, HJ ;
Torjesen, PA ;
Osterby, R ;
Bucala, R ;
Hanssen, KF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06) :661-665
[4]  
Bierhaus A, 1997, CIRCULATION, V96, P2262
[5]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[6]  
CONKLING PR, 1988, BLOOD, V72, P128
[7]   MICROALBUMINURIA - IMPLICATIONS FOR MICROVASCULAR AND MACROVASCULAR DISEASE [J].
DECKERT, T ;
KOFOEDENEVOLDSEN, A ;
NORGAARD, K ;
BORCHJOHNSEN, K ;
FELDTRASMUSSEN, B ;
JENSEN, T .
DIABETES CARE, 1992, 15 (09) :1181-1191
[8]   REGULATION OF TISSUE FACTOR GENE-EXPRESSION IN THE MONOCYTE PROCOAGULANT RESPONSE TO ENDOTOXIN [J].
GREGORY, SA ;
MORRISSEY, JH ;
EDGINGTON, TS .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (06) :2752-2755
[9]   Activated protein C resistance in type I diabetes [J].
Gruden, G ;
Olivetti, C ;
CavalloPerin, P ;
Bazzan, M ;
Stella, S ;
Tamponi, G ;
Pagano, G .
DIABETES CARE, 1997, 20 (03) :424-425
[10]   PAI-1 AND FACTOR-VII ACTIVITY ARE HIGHER IN IDDM PATIENTS WITH MICROALBUMINURIA [J].
GRUDEN, G ;
CAVALLOPERIN, P ;
BAZZAN, M ;
STELLA, S ;
VUOLO, A ;
PAGANO, G .
DIABETES, 1994, 43 (03) :426-429